[London, 30 June 2023] – Scribetech has been dramatically expanding its ecosystem of Augnito partnerships and successful integrations in order to empower more healthcare professionals with clinical documentation flexibility and a more efficient way of working.
Efficient clinical speech/voice-to-text digital dictation technology has the potential to improve clinical workflows, reduce delayed patient journeys and enable better informed outcomes. Such technology is only as effective as it is accessible, easy to adopt, easy to integrate, and easy to use.
To this end Scribetech (UK) Ltd, co-creator of Augnito, has invested in a new ecosystem of distributors, value added resellers and integration partners to help bring its AI-powered speech recognition technology to more users across the UK, starting with the new channel’s customers.
In the past three months, companies have been onboarded as distributors for Augnito Spectra – a cloud-based clinical speech recognition solution that supports any English accent, out of the box. This recent UK activity follows successful agreements with resellers in the last quarter. In addition, integration partners including Aptvision, OpenRad and Intelerad have recently integrated Augnito Voice Services into their own radiology reporting platforms, bringing higher levels of accuracy and the time-saving advantage of speech to the systems their respective medical customers already use.
This recent success aligns with Augnito’s sales and development team’s core strategy, reflecting not only a strong 2-year track record in delivering measurable savings and benefits to healthcare, but also reiterating the premier service-oriented heritage it carries from its co-developer’s solution support to the NHS in the last two decades.
More than 12,000 doctors across 355 hospitals and 24 partners in UK, USA, Canada, India, the Middle East and APAC, have signed up to Augnito in just 24 months. They are joined by 1500 radiologists and a growing number of consultants at various NHS Trusts. “Everything comes back to the mission we set out when we launched Augnito in the UK in late 2021,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito.
“We know that when access to technology is simplified from the ground up, even small increases in performance turn into huge savings. Those savings can be repurposed into what matters most – making healthcare professionals efficient at delivering exceptional care and improving patient outcomes.”
Interoperability and integration are both key to this important goal. Through Augnito Voice Services and a flexible API/SDK, healthcare technology providers can integrate speech recognition into their own platforms in a matter of weeks. To date, Cimar UK, Hexarad, Fujifilm UK Medical Systems and Magentus have all integrated Augnito technology into their radiology systems, enabling efficient workflows for their customers with more accurate diagnostic reporting.
Augnito Spectra gives users constant access to accurate speech recognition and live data input on any device running either Windows or MAC operating systems. This data is then routed securely to clinical systems including PACS and EPRs. Augnito’s ability to fit into existing clinical workflows makes user adoption easier and effective. It reduces both workload management and costs, as well as changing the way providers deploy new technology – ground up vs. top down.
Austin added: “Through our best-in-breed partnerships, we’re introducing real product flexibility and agility to assist medical health professionals in providing better patient journeys. We’ve been proactive in creating more ways to use Augnito, helping us align to the NHS plan for digital transformation and ensure new technology is integrated in a way that will naturally drive user adoption.”
For IT and technology providers in healthcare, Augnito Spectra carries a compelling (up to) 30% profit margin on every UK licence the partner sells. It is designed to be easy and fast to deploy and looks to complement partners’ existing product portfolios and service offerings. For partners’ users, Augnito Spectra provides simpler and more accurate clinical data input into all major EPR systems.
Austin concluded: “We’ve seen significant demand from resellers because the demand is there across healthcare. Inefficiencies and reporting bottlenecks are costing millions of pounds in Delayed Transfer of Care (DTOC) and bed costs as well as the ever growing patient waiting lists. And with rising demand and intense workloads, everyone inside a Trust knows something needs to change. The healthcare user benefits and the time and financial savings are significant from day one. In fact the cost of Augnito per day is less than a takeaway coffee.”
Notes to editors
About Augnito and Scribetech
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere.
Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.
While technology like clinical speech recognition has the potential to support vital transformation for mental health services, making any lasting change takes careful consideration. Funding is limited, mental health professionals are already stretched, and change can be an intimidating undertaking.
In our last post, we highlighted the significant benefits of natural speech recognition in a mental health setting. From reducing reporting time to freeing up mental health professionals (MHPs) to focus on patients, not note taking, speech-driven tools can positively impact the way people work − and the way patients receive care. But workflow benefits alone don’t determine the success of new technology.
As mental health teams begin their journey of digital transformation, they need to consider a wide range of factors including ease of implementation, adoption, security and, of course, cost.
Ease of implementation
The real cost of new technology is rarely the out-of-the-box price. The NHS Long Term Plan continues to influence technology across healthcare, but many Trusts and mental health professionals find themselves using a mix of modern solutions and older, often unwieldy platforms. As a result, IT infrastructure isn’t always ready to support a new solution, regardless of its potential benefits.
A cloud-hosted, AI-enhanced clinical speech recognition solution like Augnito completely removes this complexity, delivering intuitive speech-to-text with no need for a complex on-site implementation and no infrastructure change. And with purpose-built dictionaries for MHPs vs. a third party add-on, and no need for time-consuming voice-profile training, it’s ready to use at a moment’s notice.
All with flexible per-user licensing, a simple annual fee, and ongoing updates and support included.
Driving adoption of natural speech recognition
If a solution helps a single mental health professional save at least 30 minutes every day, that’s significant. If it’s adopted by an entire team, each experiencing the same kind of impact on their workflow, this could positively impact the patient journey for thousands of people every year. The quality of clinical records can also be improved by increasing use and adoption of the EPR/EMR, and allowing for more detail to be captured – we can speak three times faster than we can type.
An effective plan for adoption starts with ease of use. Flexibility and interoperability are key. Augnito is available wherever mental health professionals need it, whether that’s on Windows, MacOS, smartphones or tablets. Additionally, through Augnito’s comprehensive SDK and API tools, speech-to-text capabilities can also be easily integrated into existing reporting systems, alongside any data captured via Augnito. In this way, it’s easy to make clinical speech recognition part of an existing workflow − as opposed to expecting an already strained workforce to make radical changes to how they capture information and report.
At the same time, early adopters can help drive adoption across the wider team. Augnito is designed to enable MHPs to focus on their patients with more eye contact and more time to listen. Beyond improving the patient journey, speech recognition improves the lives of the people who care for patients every day. These first-hand benefits are vital to maximising adoption.
Embedded security and privacy
As is the case with the entire healthcare system, security and privacy are vital considerations in mental health. This is particularly complex when it comes to cloud-hosted software and the question of how and where data is shared.
Augnito is HIPAA, GDPR, SOC2, ISO 27001 and Cyber Essentials Plus compliant, with data encryption deeply embedded into its design process with regular audits and penetration tests to monitor security posture. All UK data is anonymised and processed in the UK, subject to the aforementioned security standards.
In fact, speech recognition has a significant privacy benefit over written documentation and reports. With all information captured digitally, MHPs can reduce the risk of misplaced documents and the manual handling errors that most commonly lead to a data breach.
Making a targeted investment in better workflows
In mental health, investment has to be targeted appropriately and in the right way. In the aftermath of the pandemic and amid a cost-of-living crisis, the scope, scale and nature of mental health complaints are all changing. The one constant is the hard work of MHPs − and it’s here that any investment in change must begin.
Augnito influences patient journeys and outcomes by enabling mental health professionals (MHPs) to work more accurately, flexibly, and effectively. It’s an investment that, while small on a per-user basis, could dramatically improve the outlook for mental health teams and patients − nationwide.
Learn more about Augnito
Augnito is already impacting the patient journey through a growing list of UK radiologists and medical consultants. Request a demo and try Augnito Spectra for 7 days to see how it can help you.